Cinacalcet HCl controls secondary hyperparathyroidism (HPT) in dialysis patients regardless of disease severity.

被引：0
|
作者：
Quarles, LD
Zeig, S
Spiegel, DM
Silver, MR
Vokes, TJ
Torregrosa, JV
Reichel, H
Horl, WH
Zani, V
Klassen, PS
Olson, KA
Turner, SA
Sprague, SM
机构：
[1] Duke Univ, Med Ctr, Durham, NC USA
[2] Pines Clin Res, Pembroke Pines, FL USA
[3] Univ Colorado, HSC, Denver, CO 80202 USA
[4] MHMC, CWRU, Cleveland, OH USA
[5] Univ Chicago Hosp, Chicago, IL 60637 USA
[6] Hosp Clin Barcelona, Barcelona, Spain
[7] Nephrol Ctr, Villingen Schwenningen, Germany
[8] Univ Vienna, Innere Med Klin 3, Vienna, Austria
[9] Amgen Inc, Thousand Oaks, CA 91320 USA
[10] Evanston Hosp Corp, Evanston, IL 60201 USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2003年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：463A / 463A
页数：1
相关论文
共 50 条
  • [1] Cinacalcet HCl controls secondary hyperparathyroidism (HPT) regardless of gender, race, age, and geography in patients with chronic kidney disease (CKD) receiving dialysis.
    Coyne, DW
    Stegman, MH
    Azad, H
    Joy, MS
    Mischel, SF
    Pokroy, N
    Ouseph, R
    Gokal, R
    Brink, HS
    Jadoul, M
    Olson, KA
    Albizem, MB
    Klassen, PS
    Chertow, GM
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 464A - 464A
  • [2] Cinacalcet HCl is an effective treatment for secondary hyperparathyroidism (HPT) in patients with chronic kidney disease (CKD) not yet receiving dialysis.
    Coburn, JW
    Charytan, C
    Chonchol, M
    Herman, J
    Lien, YH
    Liu, W
    Klassen, P
    Yahaghi, AS
    Pichette, V
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 460A - 460A
  • [3] A population pharmacokinetic (PK) and pharmacodynamic (PD) analysis of cinacalcet HCl in renal-dialysis patients with secondary hyperparathyroidism (HPT).
    Wang, B
    Ludden, T
    Gonzalez, M
    Rein, P
    Harris, R
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 75 (02) : P62 - P62
  • [4] An assessment of cinacalcet HCl effects on bone histology in dialysis patients with secondary hyperparathyroidism
    Malluche, H. H.
    Monier-Faugere, M. -C.
    Wang, G.
    Frazao, J. M.
    Charytan, C.
    Coburn, J. W.
    Coyne, D. W.
    Kaplan, M. R.
    Baker, N.
    McCary, L. C.
    Turner, S. A.
    Goodman, W. G.
    CLINICAL NEPHROLOGY, 2008, 69 (04) : 269 - 278
  • [5] Achievement of proposed NKF-K/DOQI bone metabolism and disease targets: Treatment with cinacalcet HCl in dialysis patients with uncontrolled secondary hyperparathyroidism (HPT)
    Moe, SM
    Coburn, JW
    Quarles, LD
    Goodman, WG
    Chertow, GM
    Block, GA
    Drueke, T
    Cunningham, J
    Sherrard, DJ
    McCary, LC
    Olson, KA
    Turner, SA
    Martin, KJ
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 48A - 48A
  • [6] Long-term-treatment of secondary hyperparathyroidism (HPT) with the calcimimetic cinacalcet HCl.
    Moe, SM
    Sprague, SM
    Cunningham, J
    Diueke, T
    Adler, S
    Rosansky, SJ
    Albizem, MB
    Guo, MD
    Zani, V
    Goodman, WG
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 463A - 464A
  • [7] CINACALCET FOR SECONDARY HYPERPARATHYROIDISM IN PEDIATRIC DIALYSIS PATIENTS
    Belen Martnez-lopez, Ana
    Alvarez Blanco, Olalla
    Manrique-rodrigues, Silvia
    Fernandez-llamazares, Cecilia M.
    Tejado Balsera, Juan Jose
    Morales San Jose, Maria Dolores
    Luque De Pablos, Augusto
    PEDIATRIC NEPHROLOGY, 2015, 30 (09) : 1609 - 1610
  • [8] Secondary hyperparathyroidism (HPT) in patients receiving peritoneal dialysis (PD) can be effectively managed with cinacalcet (MIMPARA®/SENSIPAR®)
    Gonzalez, M. T.
    Hutchison, A. J.
    Girndt, M.
    Stahl-Nilsson, A.
    Zani, V.
    Carter, D.
    Molemans, B.
    Bos, W. J. W.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 134 - 134
  • [9] Phase 3 experience with cinacalcet HCl in hemodialysis (HD) and peritoneal dialysis (PD) patients with secondary HPT.
    Lindberg, JS
    Culleton, B
    Wong, G
    Borah, MF
    Clark, RV
    Shapiro, WB
    Roger, SD
    Husserl, FE
    Klassen, PS
    Guo, MD
    Albizem, MB
    Coburn, JW
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 463A - 463A
  • [10] Effectiveness of Cinacalcet in Patients with Chronic Kidney Disease and Secondary Hyperparathyroidism Not Receiving Dialysis
    Perez-Ricart, Ariadna
    Galicia-Basart, Maria
    Alcalde-Rodrigo, Maria
    Segarra-Medrano, Alfons
    Sune-Negre, Josep-Maria
    Montoro-Ronsano, Jose-Bruno
    PLOS ONE, 2016, 11 (09):
12345